Takeshi Fujiwara

Takeshi Fujiwara joins Bluerock Healthcare Advisors as an esteemed member of the Advisory Board, bringing with him an extensive background in leadership roles across the healthcare and medical devices sectors. Based in Tokyo, Japan, Mr. Fujiwara currently serves as the General Manager of Cutera, Inc., a role he has held since June 2023, where he directs the company’s strategic initiatives and operational activities in advanced aesthetic systems.

Prior to his current position, Mr. Fujiwara was the CEO and President of TR3 Inc., a company he founded in January 2023. Under his leadership, TR3 Inc. has focused on consulting in the medical device field, emphasizing the import and export of medical technologies, establishing partnerships, and strategic market entry. His leadership philosophy extends beyond providing advice; he actively engages in the execution of strategies to ensure client success and societal advancement.

His extensive experience also includes a significant tenure as President of B.Braun Aesculap Japan Co., Ltd., from April 2016 to January 2023. There, he successfully managed company operations, significantly enhancing market presence and operational efficiency. His earlier roles include presidencies at Mölnlycke Health Care and GAMBRO K.K., where he led substantial growth and transformation efforts.

In addition to his executive roles, Mr. Fujiwara has held numerous esteemed positions on various boards, reflecting his broad influence and respect in the industry. He has been an active Board of Trustees member at The Swedish Chamber of Commerce and Industry in Japan since January 2015 and serves as the Vice Chairman of The JAPAN SWEDEN SOCIETY since June 2012. His contributions also extend to the German Chamber of Commerce and Industry in Japan, the Japan Association of Medical Device Industries, and the Medical Technology Association of Japan, where he has shaped significant industry policies and practices.

Mr. Fujiwara’s leadership is characterized by a commitment to fostering relationships and realizing ambitious goals, which have not only propelled his companies forward but have also contributed to broader societal benefits. His addition to the Bluerock Healthcare Advisors' Advisory Board is anticipated to bring a wealth of knowledge, strategic insight, and an expansive network, further enhancing the firm’s capabilities in navigating the complex landscape of global healthcare markets.